Mohammad I Abu Zaid

9PUBLICATIONS
45CO-AUTHORS
Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 08, 2025
Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma.

Parvathi Sudha, Travis S Johnson, Habib Hamidi

|May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma.

Travis S Johnson, Parvathi Sudha, Enze Liu

|Sep 11, 2023
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma.

Enze Liu, Parvathi Sudha, Nathan Becker

|Aug 30, 2023
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma.

Travis S Johnson, Parvathi Sudha, Enze Liu

|Jan 06, 2023
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.

David Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney

|Dec 02, 2022
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.

Carrie L Kitko, Mukta Arora, Zachariah DeFilipp

Pageof 2

Frequent Collaborators

5 joint publications

Brian A Walker

4 joint publications

Gareth Morgan

3 joint publications

Parvathi Sudha

3 joint publications

Attaya Suvannasankha

Mohammad I Abu Zaid - Author Profile | JoVE Visualize